Rogers Corp. Dl 1 Stock
Price
Target price
€120.00
€120.00
-2.440%
-3.0
-2.440%
-
29.05.26 / Frankfurt
WKN: 863178 / Name: Roger / Stock / Semiconductors & Semiconductor Equipment / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Rogers Corp. Dl 1 Stock
A loss of -2.440% shows a downward development for Rogers Corp. Dl 1.
Pros and Cons of Rogers Corp. Dl 1 in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rogers Corp. Dl 1 vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rogers Corp. Dl 1 | -2.440% | 3.448% | 5.263% | 105.128% | 51.899% | -18.367% | -21.569% |
| Universal Display Corp. | 2.030% | -0.541% | 8.890% | -35.968% | -20.589% | -43.469% | -54.353% |
| Silicon Labs Inc. | -0.530% | -0.535% | 0.541% | 75.472% | 67.568% | 37.778% | 67.568% |
| Power Integrations | -4.360% | 17.180% | 17.180% | 62.455% | 136.689% | -14.905% | 6.687% |
News
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors?
Roger E. Susi, Founder, CEO, President, and Chairman of Iradimed Corporation (NASDAQ:IRMD), reported the indirect sale of 7,500 shares of common stock over multiple transactions on May 18 and May
AEVEX Q1 Earnings Call Highlights
Key Points
- Interested in AEVEX Corp.? Here are five stocks we like better.
- Revenue and profit surged in AEVEX’s first quarter, with revenue up 307% year over year to $216.7 million and net
C&C Group H2 Earnings Call Highlights
Key Points
- Interested in C&C Group plc? Here are five stocks we like better.
- C&C Group’s FY 2026 results were weaker as group revenue fell 6% and operating profit before exceptional items